Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
CALL
The Mosaic Company
MOS
$6.8B
| $6.75M | ﹤0.01% |
311,900
-624,000
| -67% | -$14.5M |
2025 Q2
5 quarters
|
|
1877
Sarepta Therapeutics
SRPT
$2B
| $6.75M | ﹤0.01% |
370,513
-784,493
| -68% | -$14.7M |
2013 Q2
53 quarters
|
|
1878
Hartford AAA CLO ETF
TRPA
$167M
| $6.73M | ﹤0.01% |
173,241
+157,174
| +978% | +$6.12M |
2026 Q2
1 quarter
|
|
1879
CALL
3M
MMM
$100B
| $6.73M | ﹤0.01% |
+41,000
| New | +$6.99M |
2026 Q3
0 quarters
|
|
1880
PJT Partners
PJT
$4B
| $6.72M | ﹤0.01% |
47,123
-21,442
| -31% | -$3.57M |
2015 Q4
43 quarters
|
|
1881
Procept Biorobotics
PRCT
$1.25B
| $6.72M | ﹤0.01% |
368,753
-46,685
| -11% | -$931K |
2021 Q4
19 quarters
|
|
1882
Lamar Advertising Co
LAMR
$16.1B
| $6.71M | ﹤0.01% |
46,588
-1,963
| -4% | -$302K |
2013 Q2
53 quarters
|
|
1883
Pembina Pipeline
PBA
$28.4B
| $6.71M | ﹤0.01% |
149,982
+59,595
| +66% | +$2.88M |
2013 Q2
53 quarters
|
|
1884
NovoCure
NVCR
$1.71B
| $6.7M | ﹤0.01% |
420,188
+4,671
| +1% | +$78K |
2015 Q4
43 quarters
|
|
1885
Interparfums
IPAR
$3.97B
| $6.7M | ﹤0.01% |
60,396
+41,155
| +214% | +$4.86M |
2016 Q4
39 quarters
|
|
1886
Banco Bilbao Vizcaya Argentaria
BBVA
$140B
| $6.7M | ﹤0.01% |
240,353
+160,399
| +201% | +$4.45M |
2013 Q2
53 quarters
|
|
1887
Enviri
NVRI
$575M
| $6.7M | ﹤0.01% |
342,946
+114,588
| +50% | +$2.49M |
2013 Q2
53 quarters
|
|
1888
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
| $6.69M | ﹤0.01% |
70,636
-13,532
| -16% | -$1.36M |
2018 Q3
32 quarters
|
|
1889
Nexstar Media Group
NXST
$5.65B
| $6.65M | ﹤0.01% |
41,164
+29,473
| +252% | +$5.28M |
2013 Q2
53 quarters
|
|
1890
Medical Properties Trust
MPT
$1.22B
| $6.64M | ﹤0.01% |
1,918,920
+1,040,044
| +118% | +$4.37M |
2013 Q2
53 quarters
|
|
1891
JBS N.V.
JBS
$42.3B
| $6.64M | ﹤0.01% |
588,076
-805,449
| -58% | -$10.3M |
2025 Q2
5 quarters
|
|
1892
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.4B
| $6.63M | ﹤0.01% |
73,002
-26,825
| -27% | -$2.54M |
2013 Q2
53 quarters
|
|
1893
America Movil
AMX
$74.3B
| $6.63M | ﹤0.01% |
312,791
-110,651
| -26% | -$2.67M |
2013 Q2
53 quarters
|
|
1894
BioMarin Pharmaceuticals
BMRN
$10.9B
| $6.61M | ﹤0.01% |
110,176
-118,685
| -52% | -$7.47M |
2013 Q2
53 quarters
|
|
1895
Avient
AVNT
$4.31B
| $6.58M | ﹤0.01% |
163,502
-44,216
| -21% | -$1.8M |
2013 Q2
53 quarters
|
|
1896
PUT
Zions Bancorporation
ZION
$9.7B
| $6.58M | ﹤0.01% |
105,000
| – | – |
2025 Q3
4 quarters
|
|
1897
Vanguard Health Care ETF
VHT
$21.2B
| $6.55M | ﹤0.01% |
20,729
+851
| +4% | +$267K |
2013 Q2
53 quarters
|
|
1898
McEwen Inc
MUX
$920M
| $6.55M | ﹤0.01% |
366,875
+274,036
| +295% | +$5.14M |
2024 Q3
8 quarters
|
|
1899
Schwab US Large- Cap ETF
SCHX
$74.3B
| $6.54M | ﹤0.01% |
218,007
-2,534
| -1% | -$75.9K |
2021 Q1
22 quarters
|
|
1900
PUT
DaVita
DVA
$11.9B
| $6.52M | ﹤0.01% |
37,300
| – | – |
2024 Q3
8 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.